| Product Code: ETC7657167 | Publication Date: Sep 2024 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Padhi | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
In 2024, Israel`s non-injectable insulin import shipments were sourced mainly from Switzerland, UK, Belgium, USA, and Germany. With a low Herfindahl-Hirschman Index (HHI) indicating a competitive market, the compound annual growth rate (CAGR) between 2020-24 was -2.14%. However, there was a slight decline in growth from 2023 to 2024, with a growth rate of -0.41%. Despite the negative growth trend, the diverse sources of imports suggest a stable and competitive market for non-injectable insulin in Israel.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Israel Non-Injectable Insulin Market Overview |
3.1 Israel Country Macro Economic Indicators |
3.2 Israel Non-Injectable Insulin Market Revenues & Volume, 2021 & 2031F |
3.3 Israel Non-Injectable Insulin Market - Industry Life Cycle |
3.4 Israel Non-Injectable Insulin Market - Porter's Five Forces |
3.5 Israel Non-Injectable Insulin Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.6 Israel Non-Injectable Insulin Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Israel Non-Injectable Insulin Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of diabetes in Israel |
4.2.2 Growing adoption of non-injectable insulin due to ease of administration |
4.2.3 Technological advancements in non-injectable insulin delivery systems |
4.3 Market Restraints |
4.3.1 High cost of non-injectable insulin compared to traditional injectable insulin |
4.3.2 Limited reimbursement options for non-injectable insulin |
4.3.3 Regulatory hurdles and approval processes for new non-injectable insulin products |
5 Israel Non-Injectable Insulin Market Trends |
6 Israel Non-Injectable Insulin Market, By Types |
6.1 Israel Non-Injectable Insulin Market, By Product |
6.1.1 Overview and Analysis |
6.1.2 Israel Non-Injectable Insulin Market Revenues & Volume, By Product, 2021- 2031F |
6.1.3 Israel Non-Injectable Insulin Market Revenues & Volume, By Pills, 2021- 2031F |
6.1.4 Israel Non-Injectable Insulin Market Revenues & Volume, By Sprays, 2021- 2031F |
6.1.5 Israel Non-Injectable Insulin Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Israel Non-Injectable Insulin Market, By Distribution Channel |
6.2.1 Overview and Analysis |
6.2.2 Israel Non-Injectable Insulin Market Revenues & Volume, By Hospital Pharmacies, 2021- 2031F |
6.2.3 Israel Non-Injectable Insulin Market Revenues & Volume, By Online Stores, 2021- 2031F |
6.2.4 Israel Non-Injectable Insulin Market Revenues & Volume, By Drug Stores, 2021- 2031F |
7 Israel Non-Injectable Insulin Market Import-Export Trade Statistics |
7.1 Israel Non-Injectable Insulin Market Export to Major Countries |
7.2 Israel Non-Injectable Insulin Market Imports from Major Countries |
8 Israel Non-Injectable Insulin Market Key Performance Indicators |
8.1 Patient adherence rates to non-injectable insulin therapy |
8.2 Number of healthcare providers trained in prescribing and administering non-injectable insulin |
8.3 Research and development investments in improving non-injectable insulin formulations |
8.4 Number of partnerships and collaborations between pharmaceutical companies and healthcare providers for non-injectable insulin promotion |
8.5 Patient satisfaction and feedback on non-injectable insulin products |
9 Israel Non-Injectable Insulin Market - Opportunity Assessment |
9.1 Israel Non-Injectable Insulin Market Opportunity Assessment, By Product, 2021 & 2031F |
9.2 Israel Non-Injectable Insulin Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Israel Non-Injectable Insulin Market - Competitive Landscape |
10.1 Israel Non-Injectable Insulin Market Revenue Share, By Companies, 2024 |
10.2 Israel Non-Injectable Insulin Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |